HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerold Schuler Selected Research

HLA-DPw4 antigen

5/2009The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
4/2005A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells.
1/2004Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerold Schuler Research Topics

Disease

71Neoplasms (Cancer)
04/2022 - 05/2002
65Melanoma (Melanoma, Malignant)
11/2021 - 05/2002
10Neoplasm Metastasis (Metastasis)
04/2022 - 08/2004
6Pemphigus (Pemphigus Vulgaris)
05/2006 - 01/2003
5Skin Neoplasms (Skin Cancer)
07/2019 - 01/2016
4Eosinophilia
03/2020 - 01/2013
4Infections
10/2019 - 04/2007
4Lymphoma (Lymphomas)
08/2019 - 05/2006
4Leukemia
08/2019 - 12/2005
4Bullous Pemphigoid (Pemphigoid)
02/2006 - 11/2002
3Uveal melanoma
04/2022 - 12/2005
3Inflammation (Inflammations)
01/2017 - 02/2006
3Vitiligo
09/2014 - 05/2012
3Human Influenza (Influenza)
06/2005 - 06/2003
2Hypersensitivity (Allergy)
09/2021 - 01/2017
2Merkel Cell Carcinoma
06/2020 - 07/2017
2B-Cell Lymphoma (Lymphoma, B Cell)
06/2019 - 07/2006
2Myocarditis (Carditis)
01/2019 - 01/2018
2Brain Neoplasms (Brain Tumor)
06/2018 - 02/2008
2Disease Progression
01/2017 - 08/2004
2Colitis
06/2016 - 06/2015
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2007 - 01/2002
1Sclerosing Cholangitis
04/2022
1HIV Infections (HIV Infection)
01/2020
1Communicable Diseases (Infectious Diseases)
10/2019
1Dermatitis
07/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2019
1Chromosome Aberrations (Chromosome Abnormalities)
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Myasthenia Gravis
01/2019
1Myositis (Idiopathic Inflammatory Myopathies)
01/2019
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2019
1Cardiomyopathies (Cardiomyopathy)
01/2018

Drug/Important Bio-Agent (IBA)

27AntigensIBA
01/2022 - 01/2002
19Peptides (Polypeptides)IBA
10/2019 - 05/2002
14CytokinesIBA
09/2021 - 04/2003
11VaccinesIBA
01/2022 - 04/2005
10Proteins (Proteins, Gene)FDA Link
10/2019 - 01/2002
10IpilimumabIBA
01/2019 - 01/2013
9Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 04/2003
9RNA (Ribonucleic Acid)IBA
01/2022 - 06/2006
8Messenger RNA (mRNA)IBA
01/2022 - 01/2005
7Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2017
7Immune Checkpoint InhibitorsIBA
03/2020 - 01/2018
7Chimeric Antigen ReceptorsIBA
08/2019 - 10/2014
7NivolumabIBA
01/2019 - 01/2016
7T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019 - 09/2006
7AutoantibodiesIBA
03/2006 - 11/2002
6EpitopesIBA
10/2019 - 11/2002
6pembrolizumabIBA
01/2019 - 01/2016
6MART-1 AntigenIBA
01/2013 - 03/2005
5LigandsIBA
01/2019 - 07/2002
5AntibodiesIBA
01/2016 - 06/2004
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2021 - 01/2018
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021 - 01/2002
3Biological ProductsIBA
01/2017 - 01/2016
3Monophenol Monooxygenase (Tyrosinase)IBA
08/2015 - 05/2005
3HLA-DPw4 antigenIBA
05/2009 - 01/2004
3HLA-A1 Antigen (HLA A1 Antigen)IBA
05/2008 - 07/2002
3DesmogleinsIBA
03/2006 - 08/2005
3Desmoglein 3IBA
01/2006 - 01/2003
3Inosine Monophosphate (IMP)IBA
06/2005 - 06/2003
2ChemokinesIBA
09/2021 - 04/2007
2Cancer VaccinesIBA
03/2020 - 02/2011
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
10/2019 - 06/2007
2Sunscreening Agents (Sunscreens)IBA
07/2019 - 03/2017
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2018 - 12/2007
2Infliximab (Remicade)FDA Link
06/2016 - 03/2005
2HMW-MAAIBA
12/2015 - 05/2009
2CD40 Ligand (CD40L)IBA
08/2015 - 04/2012
2Pharmaceutical PreparationsIBA
01/2013 - 12/2005
2Interferon-alpha (Interferon Alfa)IBA
02/2010 - 04/2008
2Chondroitin Sulfate ProteoglycansIBA
05/2009 - 06/2007
2ChondroitinIBA
05/2009 - 06/2007
2Proteoglycans (Proteoglycan)IBA
05/2009 - 06/2007
2HLA-A*02:01 antigenIBA
07/2007 - 06/2005
2Chemokine ReceptorsIBA
04/2007 - 02/2006
2Desmoglein 1IBA
01/2006 - 08/2005
1Sorafenib (BAY 43-9006)FDA Link
04/2022
1thiamine triphosphorate (TTP)IBA
04/2022
1CollagenIBA
10/2020
1ProcalcitoninIBA
10/2019
1C-Reactive ProteinIBA
10/2019
1CD19-specific chimeric antigen receptorIBA
06/2019
1Eosinophil Cationic ProteinIBA
03/2019
1tremelimumabIBA
01/2019
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2019
1Interleukin-12 (IL 12)IBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1CateninsIBA
01/2019
1Surface Antigens (Surface Antigen)IBA
08/2018
1Small Interfering RNA (siRNA)IBA
01/2018

Therapy/Procedure

38Immunotherapy
09/2021 - 10/2002
36Therapeutics
04/2022 - 07/2002
3Cell- and Tissue-Based Therapy (Cell Therapy)
08/2019 - 10/2014
2Radiotherapy
01/2018 - 02/2008
2Lymph Node Excision (Lymph Node Dissection)
12/2017 - 02/2008
2Aftercare (After-Treatment)
06/2016 - 06/2015
2Phototherapy (Light Therapy)
09/2014 - 09/2014
2Drug Therapy (Chemotherapy)
04/2008 - 12/2005